american diabetes association history of pancreatitis glp-1 receptor agonist Understanding GLP-1 receptor agonists and their impact on drug discovery Frontiers | Exploring the multifaceted

[DOI] [Google Scholar] 55.Utzschneider K

Longer-term concerns include a potential increased risk of pancreatitis, bowel obstruction, and thyroid cancer

Moreover, a retrospective real-world study shows that both GLP1-RA and SGLT-2 inhibitors reduce the 10-year risk for cardiovascular disease in patients with T2D in primary cardiovascular prevention [17], although SGLT-2 inhibitors seem to have a greater cardioprotective benefit compared to GLP-1RA when used for secondary prevention among adults with T2D [18]

Treatment Potential of the GLP-1 Receptor Agonists in Type 2 Diabetes Mellitus: A Review

Patients often use the names interchangeably online, but the medical and insurance distinction matters